IPO registrations (S-1, F-1) · Registrants
GENVEC INC
- SEC CIK
- 934473 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 1998-04-30, last 2000-12-11; 2 initial registrations, 10 amendments
- Outcome
- Final prospectus filed 2000-12-12; withdrawal requested 1998-08-03
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 910 CLOPPER ROAD, SUITE 220N, Gaithersburg, MD 20878
- EIN
- 23-2705690
- EDGAR entity type
- operating
- Insiders and CEO pay
- GENVEC INC on the corporate pages
Offering terms
- Proposed price range
- $11.00–$12.00 per share (S-1/A filed 2000-12-11)
- Final price
- $11.88 per share, within the range (424B1 filed 2000-12-12, an initial public offering)
- Shares sold
- 4,000,000
- Gross proceeds
- $47,500,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol GNVC
- Lead underwriters
- J.P. Morgan (1,980,000 shares)
- Syndicate
- UBS (1,260,000); A.G. Edwards (360,000); Wachovia (80,000); Jackson Securities Incorporated (80,000); McDonald Investments Inc., A KeyCorp Company (80,000); Legg Mason (80,000); Needham & Company (80,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: GENVEC. INC. EXACT (EIN (EXACT))
- Federal award recipient: GENVEC, INC. Fuzzy (name and state)
- SEC filer: GENVEC INC EXACT (CIK (EXACT))
- Person page: Kevin M Rooney Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 15
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1998-04-30 | S-1 | S-1 (registration) | GENVEC INC | 0001012870-98-001149 ↗ |
| 1998-05-22 | S-1/A | S-1/A (amendment) | GENVEC INC | 0001012870-98-001416 ↗ |
| 1998-06-03 | S-1/A | S-1/A (amendment) | GENVEC INC | 0001012870-98-001497 ↗ |
| 1998-06-05 | S-1/A | S-1/A (amendment) | GENVEC INC | 0001012870-98-001515 ↗ |
| 1998-06-19 | S-1/A | S-1/A (amendment) | GENVEC INC | 0001012870-98-001635 ↗ |
| 1998-06-23 | S-1/A | S-1/A (amendment) | GENVEC INC | 0001012870-98-001659 ↗ |
| 1998-06-25 | S-1/A | S-1/A (amendment) | GENVEC INC | 0001012870-98-001684 ↗ |
| 1998-08-03 | RW | RW (withdrawal request) | GENVEC INC | 0001012870-98-001946 ↗ |
| 1998-08-03 | RW | RW (withdrawal request) | GENVEC INC | 0001012870-98-001947 ↗ |
| 2000-10-05 | S-1 | S-1 (registration) | GENVEC INC | 0000912057-00-043894 ↗ |
| 2000-11-14 | S-1/A | S-1/A (amendment) | GENVEC INC | 0000912057-00-050023 ↗ |
| 2000-11-28 | S-1/A | S-1/A (amendment) | GENVEC INC | 0000912057-00-051478 ↗ |
| 2000-12-07 | S-1/A | S-1/A (amendment) | GENVEC INC | 0000912057-00-052576 ↗ |
| 2000-12-11 | S-1/A | S-1/A (amendment) | GENVEC INC | 0000912057-00-052882 ↗ |
| 2000-12-12 | 424B1 | 424B1 (final prospectus) | GENVEC INC | 0000912057-00-053198 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-12-11 | S-1/A | registration statement | $11.00–$12.00 | $14.38 | 4,000,000 | $57,500,000 | Nasdaq GNVC | 3 | primary document; range, price sentence, shares headline, proceeds computed, cover names 3 | document ↗ |
| 2000-12-12 | 424B1 | final prospectus | $11.88 | 4,000,000 | $47,500,000 | Nasdaq GNVC | 8 | primary document; price sentence, shares headline, proceeds computed, underwriting table 8, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Davis Thomas Andrew | Officer | Chief Medical Officer | 2 | 2006 | |
| CHURCH JEFFREY WAYNE | Officer | CFO | 1 | 2006 | |
| FISCHER PAUL H | Director,Officer; Officer | Chief Executive Officer; President & CEO; President, CEO | 11 | 2006–2012 | |
| KING CHARLES RICHTER | Officer | Senior Vice President; Senior V.P. Research | 4 | 2006–2009 | |
| Butman Bryan T | Officer | Senior Vice President; Senior VP, Development; Sr. Vice President; SVP, Development | 17 | 2006–2017 | |
| Patel Nita U | Officer | Vice President | 2 | 2006–2007 | |
| Wesdyk Russell P | Officer | Vice President | 1 | 2006 | |
| HACKMAN FRANKLIN BARBARA | Director | 1 | 2006 | ||
| HOCKMEYER WAYNE T | Director | 12 | 2006–2017 | ||
| HOROVITZ ZOLA P | Director | 10 | 2006–2013 | ||
| KELLEY WILLAM N | Director | 12 | 2006–2017 | ||
| PAPADOPOULOS STELIOS | Director | 1 | 2006 | ||
| RUCH JOSHUA | Director | 7 | 2006–2010 | ||
| WERNER HAROLD R | Director | 2 | 2006–2007 | ||
| Swirsky Douglas J | Director,Officer; Officer | Chief Financial Officer; President and CEO; President & CEO; Senior Vice President & CFO | 24 | 2006–2017 | |
| Thornton Mark Owens | Officer | Senior Vice President; Senior VP, Product Development; Sr. Vice President | 9 | 2006–2010 | |
| Schneebaum Marc R | Director | 14 | 2007–2017 | ||
| Rooney Kevin M | Director | 8 | 2008–2012 | person page Fuzzy | |
| CONNOR EDWARD M | Director | 4 | 2011–2012 | ||
| MAHMOUD ADEL | Director | 4 | 2011–2012 | ||
| Brough Douglas E | Officer | Chief Scientific Officer; Senior VP, Research; SVP, Research; VP, Research | 9 | 2011–2017 | |
| Tucker Michael C | Officer | VP, Legal Affairs and Strategy | 2 | 2011–2012 | |
| Collins Cynthia | Director,Officer | President & CEO | 3 | 2012–2013 | |
| Loren Stefan | Director | 10 | 2013–2017 | ||
| EcoR1 Capital Fund, L.P. | Other; TenPercentOwner | 3 | 2013–2014 | ||
| EcoR1 Capital, LLC | TenPercentOwner | 3 | 2013–2014 | ||
| NODELMAN OLEG | TenPercentOwner | 3 | 2013–2014 | ||
| EcoR1 Capital Fund Qualified, L.P. | Other | 3 | 2014 | ||
| Mallette Quinterol J | Director | 6 | 2014–2017 | ||
| Lambert James Vincent | Officer | Sr. Director, Corp Controller; VP, Accounting & Finance | 5 | 2014–2017 | |
| Richman Michael | Director | 5 | 2015–2017 | ||
| MMCAP International Inc. SPC | TenPercentOwner | 2 | 2017 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | GENVEC INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | GENVEC. INC. | EIN (EXACT) | ||
| Federal award recipient | GENVEC, INC. | Federal spending (USAspending) | name and state | |
| Person page | Kevin M Rooney | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.